Pfizer and BioNTech plan to seek authorization for second COVID booster for people 65 and up

Pfizer and its partner BioNTech plan to seek emergency authorization for a second COVID-19 booster shot for people 65 and older, Axios has confirmed. Driving the news: The move is an attempt to combat waning immunity that occurs several months after a first b…
Read More